Opinion
Video
Author(s):
In the third installment of this series, Amar U. Kishan, MD, discusses clinical factors to consider in the use of perirectal spacing for patients receiving hypofractionation or SBRT, and outlines unmet needs.
Real-world studies underline safety, efficacy of radium-223 in mCRPC
Dr. Murphy on increasing diversity in cancer clinical trials
Radium-223 re-treatment is safe in patients with mCRPC
Dr. Schwen on focal therapies for prostate cancer
Race subgroup analysis points to clinical benefit of darolutamide in nmCRPC
STOPCAP: ARPIs benefit younger patients with mHSPC